Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events

Department of Entomology and University of California-Davis Cancer Center, University of California, Davis, CA 95616, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 09/2010; 107(39):17017-22. DOI: 10.1073/pnas.1011278107
Source: PubMed

ABSTRACT Chronic administration of high levels of selective COX-2 inhibitors (coxibs), particularly rofecoxib, valdecoxib, and parecoxib, increases risk for cardiovascular disease. Understanding the possibly multiple mechanisms underlying these adverse cardiovascular events is critical for evaluating the risks and benefits of coxibs and for development of safer coxibs. The current understanding of these mechanisms is likely incomplete. Using a metabolomics approach, we demonstrate that oral administration of rofecoxib for 3 mo results in a greater than 120-fold higher blood level of 20-hydroxyeicosatetraenoic acid (20-HETE), which correlates with a significantly shorter tail bleeding time in a murine model. We tested the hypothesis that this dramatic increase in 20-HETE is attributable to inhibition of its metabolism and that the shortened bleeding time following rofecoxib administration is attributable, in part, to this increase. The s.c. infusion of 20-HETE shortened the tail bleeding time dramatically. Neither 20-HETE biosynthesis nor cytochrome P4A-like immune reactivity was increased by rofecoxib administration, but 20-HETE production increased in vitro with the addition of coxib. 20-HETE is significantly more potent than its COX-mediated metabolites in shortening clotting time in vitro. Furthermore, 20-HETE but not rofecoxib significantly increases rat platelet aggregation in vitro in a dose-dependent manner. These data suggest 20-HETE as a marker of rofecoxib exposure and that inhibition of 20-HETE's degradation by rofecoxib is a partial explanation for its dramatic increase, the shortened bleeding time, and, possibly, the adverse cardiovascular events associated with rofecoxib.

Download full-text


Available from: Jun Yang, Aug 19, 2015
  • Source
    • "The recent rapid development of a range of analytical platforms, including gas chromatography (GC), liquid chromatography (LC), high pressure LC (HPLC), ultra pressure LC (UPLC) coupled to mass spectrometry (MS), capillary electrophoresis (CE) coupled to MS, Fourier Transform Infrared (FTIR) spectroscopy, and nuclear magnetic resonance (NMR) [e.g., proton ( 1 H)-NMR] spectroscopy , can enable to separate, detect, characterize, and quantify such metabolites and related metabolic pathways (Zhang et al., 2011). Metabolomics focuses on the complex interactions of system components and highlights the whole system rather than the individual parts, providing a distinct perspective on cellular homeostasis (Liu et al., 2010). Even if nowadays NMR, GC-MS, LC-MS are the prevalent techniques used, none of them is a perfect technique that can meet the requirements of metabolomics for measuring all metabolites. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacteria colonizing the human intestinal tract exhibit a high phylogenetic diversity that reflects their immense metabolic potentials. The catalytic activity of gut microbes has an important impact on gastrointestinal (GI) functions and host health. The microbial conversion of carbohydrates and other food components leads to the formation of a large number of compounds that affect the host metabolome and have beneficial or adverse effects on human health. Metabolomics is a metabolic-biology system approach focused on the metabolic responses understanding of living systems to physio-pathological stimuli by using multivariate statistical data on human body fluids obtained by different instrumental techniques. A metabolomic approach based on an analytical platform could be able to separate, detect, characterize and quantify a wide range of metabolites and its metabolic pathways. This approach has been recently applied to study the metabolic changes triggered in the gut microbiota by specific diet components and diet variations, specific diseases, probiotic and synbiotic food intake. This review describes the metabolomic data obtained by analyzing human fluids by using different techniques and particularly Gas Chromatography Mass Spectrometry Solid-phase Micro Extraction (GC-MS/SPME), Proton Nuclear Magnetic Resonance ((1)H-NMR) Spectroscopy and Fourier Transform Infrared (FTIR) Spectroscopy. This instrumental approach has a good potential in the identification and detection of specific food intake and diseases biomarkers.
    Frontiers in Cellular and Infection Microbiology 12/2012; 2:156. DOI:10.3389/fcimb.2012.00156 · 2.62 Impact Factor
  • Source
    • "Metabolomics, using top-down systems, aims to achieve understanding of differences between beneficial and pathological interventions in a living organism. The metabolites (e.g., sugars, carbohydrates, amino acids and lipids) could yield important information about a person's health or disease (Wikoff et al., 2009; Minami et al., 2009; Liu et al., 2010). It is important to note that these metabolites are being explored extensively as putative markers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Systems biology has significantly increased in recent years. Its method and design resemble those of traditional Chinese medicine (TCM), which is a unique medical system that assisted the ancient Chinese in dealing with disease. The technology platforms of systems biology, especially metabolomics, could provide more rapid, direct, concise and effective methods for disease research. In particular, metabolomics could provide useful tools for exploring the essence of Chinese medicine syndromes (CMS) disease, facilitating personalized TCM. Moreover, metabolomics has the potential to enable mapping of early biochemical changes in disease and hence provide an opportunity to develop predictive biomarkers that can trigger earlier interventions. A future hope for the metabonomic approach is the identification of biomarkers that are able to highlight individuals likely to suffer from disease and enable early diagnosis of the disease or the identification of those at risk, and it will help to understand CMS and modernize TCM. In this review, we focus on the key role of robust metabolomic approaches as an aid for traditional herbal medicine; particular attention will be paid to the past successes in applications of metabonomics to contribute to low-molecular-weight metabolites (biomarkers) discovery in TCM research. Copyright © 2012 John Wiley & Sons, Ltd.
    Phytotherapy Research 03/2012; 26(10):1466-71. DOI:10.1002/ptr.4613 · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A series of dual inhibitors containing a 1,5-diarylpyrazole and a urea were designed, synthesized, and evaluated as novel COX-2/sEH dual inhibitors in vitro using recombinant enzyme assays and in vivo using a lipopolysaccharide (LPS) induced model of pain in rats. The best inhibition potencies and selectivity for sEH and COX-2 over COX-1 were obtained with compounds (21b, 21i, and 21j) in which both the 1,5-diaryl-pyrazole group and the urea group are linked with a three-methylene group. Compound 21i showed the best pharmacokinetic profiles in both mice and rats (higher AUC and longer half-life). Following subcutaneous administration at 10 mg/kg, compound 21i exhibited antiallodynic activity that is more effective than the same dose of either a COX-2 inhibitor (celecoxib) or a sEH inhibitor (t-AUCB) alone, as well as coadministration of both inhibitors. Thus, these novel dual inhibitors exhibited enhanced in vivo antiallodynic activity in a nociceptive behavioral assay.
Show more